Efg Asset Management (Americas) Corp. Alnylam Pharmaceuticals, Inc. Transaction History

Efg Asset Management (Americas) Corp.

$488 Million
Q1 2025

A detailed history of Efg Asset Management (Americas) Corp. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 13,372 shares of ALNY stock, worth $5.87 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

13,372

Previous 14,946 10.53%

Holding current value

$5.87 Million

Previous $3.52 Million 2.67%

% of portfolio

0.74%

Previous 0.69%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$233.07 - $290.7 $366,852 - $457,561	-1,574 Reduced 10.53%	13,372 $3.61 Million
Q4 2024 Feb 06, 2025	SELL	$232.27 - $300.43 $1,625 - $2,103	-7 Reduced 0.05%	14,946 $3.52 Million
Q3 2024 Nov 12, 2024	SELL	$233.81 - $287.01 $476,738 - $585,213	-2,039 Reduced 12.0%	14,953 $4.11 Million
Q2 2024 Aug 06, 2024	BUY	$143.31 - $247.0 $875,050 - $1.51 Million	6,106 Added 56.09%	16,992 $4.13 Million
Q1 2024 Apr 22, 2024	SELL	$146.51 - $198.2 $786,026 - $1.06 Million	-5,365 Reduced 33.01%	10,886 $1.63 Million
Q4 2023 Feb 01, 2024	BUY	$151.41 - $196.57 $120,219 - $156,076	794 Added 5.14%	16,251 $3.11 Million
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $47,474 - $58,838	-278 Reduced 1.77%	15,457 $2.74 Million
Q2 2023 Aug 29, 2023	BUY	$185.01 - $212.05 $102,865 - $117,899	556 Added 3.66%	15,735 $2.99 Million
Q1 2023 May 04, 2023	SELL	$182.66 - $235.53 $43,473 - $56,056	-238 Reduced 1.54%	15,179 $3.04 Million
Q4 2022 Feb 09, 2023	BUY	$185.53 - $241.31 $51,020 - $66,360	275 Added 1.82%	15,417 $3.66 Million
Q3 2022 Nov 07, 2022	BUY	$138.54 - $232.0 $262,256 - $439,176	1,893 Added 14.29%	15,142 $3.03 Million
Q2 2022 Jul 13, 2022	SELL	$120.42 - $169.29 $420,145 - $590,652	-3,489 Reduced 20.84%	13,249 $1.93 Million
Q1 2022 May 05, 2022	BUY	$127.18 - $173.91 $2.13 Million - $2.91 Million	16,738 New	16,738 $2.73 Million
Q3 2021 Oct 22, 2021	SELL	$169.75 - $207.73 $4.45 Million - $5.44 Million	-26,187 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$128.63 - $176.89 $224,716 - $309,026	1,747 Added 7.15%	26,187 $4.44 Million
Q1 2021 Apr 09, 2021	BUY	$126.83 - $175.69 $129,366 - $179,203	1,020 Added 4.36%	24,440 $3.45 Million
Q4 2020 Feb 05, 2021	BUY	$122.97 - $147.0 $287,872 - $344,127	2,341 Added 11.11%	23,420 $3.04 Million
Q3 2020 Nov 06, 2020	BUY	$121.19 - $165.49 $2.55 Million - $3.49 Million	21,079 New	21,079 $3.07 Million

Others Institutions Holding ALNY

# of Institutions

746

Shares Held

110M

Call Options Held

966K

Put Options Held

841K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $54B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.

Account

Efg Asset Management (Americas) Corp. Alnylam Pharmaceuticals, Inc. Transaction History